Literature DB >> 24798971

Plasma ferritin levels, HFE polymorphisms, and risk of pancreatic cancer among Chinese Han population.

Zhiming Zhao1, Chenggang Li, Minggeng Hu, Jidong Li, Rong Liu.   

Abstract

The etiology of pancreatic cancer (PC) remains poorly understood. High iron levels can increase the formation of noxious oxygen radicals, which are thought to promote carcinogenesis. The aim of this study was to determine whether iron biomarkers and HFE genotypes, which influence iron regulation, constitute risk factors for PC. A case-control study was conducted to examine plasma ferritin levels (n = 1,000 cases; 1,004 controls), two hemochromatosis gene (HFE) SNPs (n = 1,386 cases; 1,386 controls), and PC risk. Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated by unconditional logistic regression. We did not observe a significant association between plasma ferritin and PC risk. However, HFE rs1799945 was significantly associated with PC risk, with each additional copy of minor allele T being associated with a 1.21-fold increased risk of PC (OR = 1.21, 95 % CI 1.05-1.39, P = 7.72 × 10(-3)). Overall, high iron levels do not increase the risk of PC. Our observation that HFE rs1799945 increased PC risk warrants replication in additional study populations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24798971     DOI: 10.1007/s13277-014-1978-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

1.  Induction of sarcoma in the rat by iron-dextran complex.

Authors:  H G RICHMOND
Journal:  Br Med J       Date:  1959-04-11

2.  Hfe mutations and iron overload in patients with alcoholic liver disease.

Authors:  Luís Costa-Matos; Paulo Batista; Nuno Monteiro; Pedro Henriques; Fernando Girão; Armando Carvalho
Journal:  Arq Gastroenterol       Date:  2013 Jan-Mar

3.  HFE gene C282Y variant is associated with colorectal cancer in Caucasians: a meta-analysis.

Authors:  Weidong Chen; Hua Zhao; Tiegang Li; Hongliang Yao
Journal:  Tumour Biol       Date:  2013-04-04

4.  Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.

Authors:  Rebecca E Graff; Eunyoung Cho; Sara Lindström; Peter Kraft; Walter C Willett; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01-17       Impact factor: 4.254

Review 5.  Iron homeostasis in breast cancer.

Authors:  Oriana Marques; Berta Martins da Silva; Graça Porto; Carlos Lopes
Journal:  Cancer Lett       Date:  2014-01-31       Impact factor: 8.679

6.  H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment.

Authors:  Fatima Ali-Rahmani; Patricia S Grigson; Sang Lee; Elizabeth Neely; James R Connor; Cara-Lynne Schengrund
Journal:  Neurobiol Aging       Date:  2013-12-25       Impact factor: 4.673

7.  A mutation in the HFE gene is associated with altered brain iron profiles and increased oxidative stress in mice.

Authors:  Wint Nandar; Elizabeth B Neely; Erica Unger; James R Connor
Journal:  Biochim Biophys Acta       Date:  2013-02-18

8.  Body iron stores and risk of colonic neoplasia.

Authors:  R L Nelson; F G Davis; E Sutter; L H Sobin; J W Kikendall; P Bowen
Journal:  J Natl Cancer Inst       Date:  1994-03-16       Impact factor: 13.506

9.  HFE genotypes in patients with chronic pancreatitis and pancreatic adenocarcinoma.

Authors:  Tomas Hucl; Marja-Leena Kylanpää-Bäck; Heiko Witt; Beat Künzli; Marko Lempinen; Alexander Schneider; Esko Kemppainen; Matthias Löhr; Helmut Friess; Johann Ockenga; Jonas Rosendahl; Hans-Ulrich Schulz; Thomas Gress; Manfred V Singer; Roland H Pfützer
Journal:  Genet Med       Date:  2007-07       Impact factor: 8.822

10.  Dietary heme iron and the risk of colorectal cancer with specific mutations in KRAS and APC.

Authors:  Anne M J Gilsing; Fiona Fransen; Theo M de Kok; Alexandra R Goldbohm; Leo J Schouten; Adriaan P de Bruïne; Manon van Engeland; Piet A van den Brandt; Anton F P M de Goeij; Matty P Weijenberg
Journal:  Carcinogenesis       Date:  2013-08-27       Impact factor: 4.944

View more
  6 in total

1.  The association between serum ferritin with colorectal cancer.

Authors:  Zhe Feng; Ji-Wei Chen; Jian-Hua Feng; Fei Shen; Wen-Song Cai; Jie Cao; Bo Xu
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Hereditary Hemochromatosis Variant Associations with Incident Nonliver Malignancies: 11-Year Follow-up in UK Biobank.

Authors:  Janice L Atkins; Luke C Pilling; Suzy V Torti; Frank M Torti; George A Kuchel; David Melzer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

3.  Hemochromatosis, Iron Overload-Related Diseases, and Pancreatic Cancer Risk in the Surveillance, Epidemiology, and End Results (SEER)-Medicare.

Authors:  Sachelly Julián-Serrano; Fangcheng Yuan; Michael J Barrett; Ruth M Pfeiffer; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-03       Impact factor: 4.090

4.  Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.

Authors:  Zuzana Rychtarcikova; Sandra Lettlova; Veronika Tomkova; Vlasta Korenkova; Lucie Langerova; Ekaterina Simonova; Polina Zjablovskaja; Meritxell Alberich-Jorda; Jiri Neuzil; Jaroslav Truksa
Journal:  Oncotarget       Date:  2017-01-24

5.  Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies.

Authors:  Sachelly Julián-Serrano; Fangcheng Yuan; William Wheeler; Beben Benyamin; Mitchell J Machiela; Alan A Arslan; Laura E Beane-Freeman; Paige M Bracci; Eric J Duell; Mengmeng Du; Steven Gallinger; Graham G Giles; Phyllis J Goodman; Charles Kooperberg; Loic Le Marchand; Rachel E Neale; Xiao-Ou Shu; Stephen K Van Den Eeden; Kala Visvanathan; Wei Zheng; Demetrius Albanes; Gabriella Andreotti; Eva Ardanaz; Ana Babic; Sonja I Berndt; Lauren K Brais; Paul Brennan; Bas Bueno-de-Mesquita; Julie E Buring; Stephen J Chanock; Erica J Childs; Charles C Chung; Eleonora Fabiánová; Lenka Foretová; Charles S Fuchs; J Michael Gaziano; Manuel Gentiluomo; Edward L Giovannucci; Michael G Goggins; Thilo Hackert; Patricia Hartge; Manal M Hassan; Ivana Holcátová; Elizabeth A Holly; Rayjean I Hung; Vladimir Janout; Robert C Kurtz; I-Min Lee; Núria Malats; David McKean; Roger L Milne; Christina C Newton; Ann L Oberg; Sandra Perdomo; Ulrike Peters; Miquel Porta; Nathaniel Rothman; Matthias B Schulze; Howard D Sesso; Debra T Silverman; Ian M Thompson; Jean Wactawski-Wende; Elisabete Weiderpass; Nicolas Wenstzensen; Emily White; Lynne R Wilkens; Herbert Yu; Anne Zeleniuch-Jacquotte; Jun Zhong; Peter Kraft; Dounghui Li; Peter T Campbell; Gloria M Petersen; Brian M Wolpin; Harvey A Risch; Laufey T Amundadottir; Alison P Klein; Kai Yu; Rachael Z Stolzenberg-Solomon
Journal:  Am J Clin Nutr       Date:  2021-10-04       Impact factor: 8.472

Review 6.  Iron Metabolism in Cancer Progression.

Authors:  Stefania Forciniti; Luana Greco; Fabio Grizzi; Alberto Malesci; Luigi Laghi
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.